跳至主要内容
临床试验/TCTR20211005001
TCTR20211005001进行中(未招募)不适用

Immunogenicity of the 3rd COVID-19 vaccine dose in Thai healthcare workers at Bamrasnaradura Infectious Diseases Institute

ational Research Council of Thailand (NRCT)0 个研究点目标入组 170 人开始时间: 2021年10月5日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Age 18 years or more
  • 2. Healthcare workers at Bamrasnaradura Infectious Diseases Institute
  • 3. Received 2nd dose of Sinovac at least 21 days before
  • 4. Eligible for ChAdOx1/AZD1222 COVID-19 vaccine
  • 5. Informed consent for participation

排除标准

  • Allergy to a component of ChAdOx1/AZD1222 COVID-19 Vaccine

研究者

发起方
ational Research Council of Thailand (NRCT)

相似试验

已完成
Unknown
Immune response to a third COVID-19 vaccine dose in people with multiple sclerosis receiving B cell-depleting therapyImmunosuppressionCOVID-19 vaccinationNeurological - Multiple sclerosisInfection - Other infectious diseasesMultiple Sclerosis
ACTRN12623001249640Royal Adelaide Hospital53
招募中
2 期
Immunogenicity and safety of the third dose COVID-19 vaccine in Thai population.After the third dose of the COVID-19 vaccine, the immune response in healthy volunteers who received 2 doses of COVID19 vaccine (CoronaVac or ChAdOx1) at least three months.COVID-19 vaccine, Third dose, ChAdOx1, coronavac, Sinovac, BNT162b2, Sinopharm
TCTR20210731004Chulabhorn Royal Academy5,520
招募中
2 期
Immunogenicity and safety of the third dose COVID-19 vaccine via intradermal compare with intramuscular administration (Randomized controlled trial)The immune response after the third dose of the COVID-19 vaccine via intradermal administration in healthy volunteers.COVID-19 vaccine, Third dose, intradermal, ChAdOx1, coronavac, Sinovac, BNT162b2, mRNA1263, Sinopharm
TCTR20210731003Chulabhorn Royal Academy960
Unknown
3 期
Safety and immunogenicity of the third COVID-19 vaccines booster dose in children (12-18 years) with completed 2 doses as recommended by the ministry of public healthHealth adolescentsCOVID-19, booster, vaccine
TCTR20221215006Chulalongkorn University320
招募中
不适用
Pattern of antibody response after 3rd dose of COVID-19 vaccine booster among healthy volunteers.Healthy volunteerCOVID-19 Vaccinesadministration and dosageimmunology
TCTR20210831002akornping Hospital180